NYSE:ABC (USA) Also trade in: Germany

AmerisourceBergen Corp

$ 73.72 -0.37 (-0.5%)
Volume: 1,006,672 Avg Vol (1m): 1,490,754
Market Cap $: 15.56 Bil Enterprise Value $: 17.46 Bil
P/E (TTM): 13.47 P/B: 5.11
Earnings Power Value 67.44
Net Current Asset Value -41.43
Tangible Book -31.15
Projected FCF 118.67
Median P/S Value 102.86
Graham Number 0
Peter Lynch Value 136.75
DCF (FCF Based) 142.77
DCF (Earnings Based) 58.54
YTD (-%)

Financial Strength : 6/10

Current vs industry vs history
Cash-to-Debt 0.59
Equity-to-Asset 0.08
Debt-to-Equity 1.42
Debt-to-EBITDA 2.18
Interest Coverage 8.08
Piotroski F-Score 7
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.87
DISTRESS
GREY
SAFE
Beneish M-Score -2.37
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 29.79%
WACC 10.29%

Profitability & Growth : 8/10

Current vs industry vs history
Operating Margin % 0.94
Net Margin % 0.69
ROE % 39.30
ROA % 3.13
ROC (Joel Greenblatt) % 76.75
3-Year Total Revenue Growth Rate 7.30
3-Year Total EBITDA Growth Rate 44.20

» ABC's 30-Y Financials

Financials (Next Earnings Date: 2019-05-02)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NYSE:ABC

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Distribution » Medical Distribution    NAICS : 424210    SIC : 5122
Compare NYSE:CAH XKRX:091990 NAS:HSIC HKSE:01099 SHSE:601607 NYSE:MCK TSE:7459 SZSE:002589 SHSE:600056 SZSE:200028 LSE:UDG SHSE:600763 NAS:PDCO NZSE:EBO SHSE:600090 NYSE:PBH LSE:CLIN SHSE:603368 TSE:7476 NYSE:OMI
Traded in other countries ABG.Germany
Address 1300 Morris Drive, Chesterbrook, PA, USA, 19087-5594
AmerisourceBergen is one of three major pharmaceutical distributors in the U.S., with highly efficient distribution assets. The firm's activities include procurement, inventory management, reimbursement consulting, sales forecasts, and logistics services. The firm is also a wholesale leader within the high-growth specialty distribution niche.

Ratios

Current vs industry vs history
PE Ratio (TTM) 13.47
Forward PE Ratio 10.94
N/A
PE Ratio without NRI 13.47
Price-to-Owner-Earnings 12.54
PB Ratio 5.11
PS Ratio 0.09
Price-to-Free-Cash-Flow 10.42
Price-to-Operating-Cash-Flow 8.52
EV-to-EBIT 12.01
EV-to-EBITDA 8.78
EV-to-Revenue 0.10
PEG Ratio 0.75
Shiller PE Ratio 24.27
Current Ratio 0.94
Quick Ratio 0.53
Days Inventory 26.36
Days Sales Outstanding 25.29
Days Payable 61.54

Dividend & Buy Back

Current vs industry vs history
Dividend Yield % 2.12
Dividend Payout Ratio 0.28
3-Year Dividend Growth Rate (Per Share) 9.40
Forward Dividend Yield % 2.16
N/A
Yield-on-Cost (5-Year) % 3.99
3-Year Share Buyback Rate -1.00

Valuation & Return

Current vs industry vs history
Price-to-Projected-FCF 0.62
Price-to-DCF (Earnings Based) 1.26
Price-to-Median-PS-Value 0.72
Price-to-Peter-Lynch-Fair-Value 0.54
Earnings Yield (Joel Greenblatt) % 8.33
Forward Rate of Return (Yacktman) % 31.62

More Statistics

Revenue (TTM) (Mil) $ 172,865.76
EPS (TTM) $ 5.47
Beta 1.53
Volatility % 27.73
52-Week Range $ 69.36 - 95
Shares Outstanding (Mil) 211.09

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 7
Positive ROA Y
Positive CFROA Y
Higher ROA yoy Y
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy N
Less Shares Outstanding yoy Y
Higher Gross Margin yoy N
Higher Asset Turnover yoy Y